|
2024
|
Invention
|
Treatment of hcm with pyrimidinedione compounds.
Provided are methods for treating hypertrophic ... |
|
|
G/S
|
Health care services, namely, providing information to physicians, health care professionals and ... |
|
|
Invention
|
Myosin inhibitors for use in the treatment of hypertrophic cardiomyopathy. Methods of using myosi... |
|
|
Invention
|
Pyrimidinedione compounds.
Provided are novel pyrimidine dione compounds and pharmaceutically ac... |
|
2023
|
Invention
|
Methods of administering myosin inhibitors.
Methods of administering a myosin inhibitor to a pat... |
|
|
Invention
|
Mavacamten and derivatives thereof for use in treating atrial dysfunction. Provided herein are me... |
|
|
Invention
|
Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases.
... |
|
|
Invention
|
Crystalline forms of (6s,7s)-6-fluoro-7-(2-fluoro-5-methylphenyl)- 3-(tetrahydro-2h-pyran-4-yl)-5... |
|
|
Invention
|
Methods of administering myosin inhibitors. Methods of administering a myosin inhibitor to a pati... |
|
|
G/S
|
Pharmaceutical preparations for human use. |
|
|
G/S
|
Pharmaceutical preparations for human use. |
|
2022
|
G/S
|
Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders |
|
|
Invention
|
Pyrimidinedione compounds. Provided are novel pyrimidine dione compounds and pharmaceutically acc... |
|
|
Invention
|
Polymorphic forms of (r)-4-(1-((3-(difluoromethyl)-1-methyl-1h-pyrazol-4-yl)sulfonyl)-1-fluoroeth... |
|
2021
|
G/S
|
Pharmaceutical and biological preparations for human use. |
|
|
Invention
|
Methods of treatment with myosin modulator.
Methods of treatment comprising administering a ther... |
|
|
Invention
|
Methods of treatment with myosin modulator. Methods of treatment comprising administering a thera... |
|
|
Invention
|
4-methylsulfonyl-substituted piperidine urea compounds.
The present invention provides novel 4-m... |
|
|
G/S
|
Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders. |
|
|
G/S
|
Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders |
|
|
Invention
|
Treatment of atrial dysfunction.
Provided herein are methods, uses, and compositions for treatin... |
|
|
Invention
|
Treatment of atrial dysfunction. Provided herein are methods, uses, and compositions for treating... |
|
|
G/S
|
Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinen... |
|
2020
|
Invention
|
Methods of treatment with myosin modulator.
Disclosed herein are methods of treatment comprising... |
|
|
Invention
|
Methods of treatment with myosin modulator. Disclosed herein are methods of treatment comprising ... |
|
|
Invention
|
4-methylsulfonyl-substituted piperidine urea compounds. The present invention provides novel 4-me... |
|
|
Invention
|
Diagnostics and treatments for cardiac disease. e.ge.g., oHCM score or AS score). |
|
|
Invention
|
Treatment of systolic dysfunction and heart failure with reduced ejection fraction with the compo... |
|
|
G/S
|
Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders |
|
|
G/S
|
Providing funding and research grants to researchers and clinicians for supporting research; fina... |
|
|
G/S
|
Providing funding and research grants to researchers and clinicians; providing funding and resear... |
|
|
G/S
|
Pharmaceutical preparations for prevention and treatment of cardiovascular diseases and disorders... |
|
2019
|
G/S
|
Pharmaceutical preparations and substances; pharmaceutical preparations for prevention, diagnosis... |
|
|
Invention
|
Substituted 5,6,7,8-tetrahydropyrido[2,3-d]pyrimidine-2,4-diones for treating cardiac diseases. T... |
|
|
Invention
|
Tetrahydropyran (thp)-substituted bicyclic-pyrimidinedione compounds. The present disclosure prov... |
|
|
Invention
|
Pyrazole compounds and preparation thereof. 7 is selected from H, CI or trialkylsilyl.
|
|
|
Invention
|
Pyrazole compounds and preparation thereof. The present invention provides processes for preparat... |
|
2018
|
Invention
|
Mavacamten for use in the treatment of hypertrophic cardiomyopathy. Provided are methods for trea... |
|
2016
|
Invention
|
Sensor for ventricular and outflow tract obstruction. Systems and methods for identifying LVOT ob... |
|
|
Invention
|
Sensor for ventricular and outflow tract obstruction.
Systems and methods for identifying LVOT o... |
